PPTA's 2012 Plasma Protein Forum

Over 300 patients, policymakers and industry representatives convened in Washington, DC on June 21-22 for the 2012 Plasma Protein Forum. The conference centered on the theme of rare diseases.

Highlights of the 2012 Forum:

Myrl Weinberg, President of the National Health Council delivered a dynamic keynote assessing risk and benefit from a patient perspective.

0736 Myrl
0725 Burgess

The Honorable Michael C. Burgess, (R-TX), outlined health policy perspectives from the U.S. Congress. Other presentations and panels addressed the impact of the Affordable Health Care Act on the States, the cost effectiveness of plasma protein therapies.


0712 Welcome

PPTA staff welcomes attendees to the Forum

0718 Burgess

Kym Kilbourne, Congressman Michael Burgess and
Jan M. Bult


0779 Meixner

Josh Penrod presents Rudolf Meixner,
President, Europlasma GmbH with IQPP certification -- the first in the Czech Republic

0816 Carlisle

Ileana Carlisle delivers a testament to industry in final act as Source Board Chair


0715 Exhibits

Exhibitors demonstrate the latest industry innovations

0756 Connect

Attendees enjoy informal opportunities to connect


0808 Award

Steve Pettaway received the Otto Schwarz Award
for leadership in the industry and scientific fields of expertise

0807 Award-Healey

 Otto Schwarz Award accepted by Christopher Healey, Grifols

  • Created on .
Copyright © 2022 PPTA. All rights reserved. (202) 789-3100